Yearly Trends of Chronic Kidney Disease III Progressions in Living Kidney Donors

Hyung Ho Lee, Joon Chae Na, Young Eun Yoon, Hyung Soon Lee, Kyu Ha Huh, Yu Seun Kim, Woong Kyu Han

Research output: Contribution to journalArticle

Abstract

Purpose: We aim to see the rate of progression to chronic kidney disease stage III after living donor nephrectomy in a single institution annually. Methods: Between May 2006 and July 2017, a total of 753 living kidney donors who were followed up more than 6 months were enrolled in the study. We divided normal function vs chronic kidney disease III at 6 months postoperatively. We compared the incidence rate of chronic kidney disease stage III annually. For analysis, the entire period was divided into Era 1 (2006–2008), Era 2 (2009–2011), Era 3 (2012–2014), and Era 4 (2015–2017). Results: During the period, the incidence of chronic kidney disease stage III was 258 living donors (34.3%). The prevalence of chronic kidney disease stage III was 39.3%, 36.6%, 35.5%, and 29.3% in Era 1, Era 2, Era 3, and Era 4, respectively. The rate of chronic kidney disease stage III incidence serially decreased as the era passed (P = .046). There was no difference in age, smoking status, drinking status, body mass index, preoperative cholesterol, and uric acid among the eras. However, preoperative estimated glomerular filtration rate was 90.86 (SD, 4.12), 94.47 (SD, 16.62), 103.82 (SD, 0.68), and 105.66 (SD, 19.57) mL/min/1.73 m2 in Era 1, Era 2, Era 3, and Era 4, respectively (P = .001). Conclusions: The incidence of chronic kidney disease stage III in living kidney donors for the last 3 years (Era 4) has decreased compared with the past (Era 1 and 2). The reason for this might be the effect of the change in the living donor guideline. Also, pre- and postoperative management method had an effect on renal function at 6 months.

Original languageEnglish
Pages (from-to)2539-2542
Number of pages4
JournalTransplantation Proceedings
Volume51
Issue number8
DOIs
Publication statusPublished - 2019 Oct

Fingerprint

Living Donors
Chronic Renal Insufficiency
Disease Progression
Kidney
Incidence
Uric Acid
Nephrectomy
Glomerular Filtration Rate
Drinking
Body Mass Index
Smoking
Cholesterol
Guidelines

All Science Journal Classification (ASJC) codes

  • Surgery
  • Transplantation

Cite this

Lee, Hyung Ho ; Na, Joon Chae ; Yoon, Young Eun ; Lee, Hyung Soon ; Huh, Kyu Ha ; Kim, Yu Seun ; Han, Woong Kyu. / Yearly Trends of Chronic Kidney Disease III Progressions in Living Kidney Donors. In: Transplantation Proceedings. 2019 ; Vol. 51, No. 8. pp. 2539-2542.
@article{682d8b305c7646adafee8ff2ae9fc7a3,
title = "Yearly Trends of Chronic Kidney Disease III Progressions in Living Kidney Donors",
abstract = "Purpose: We aim to see the rate of progression to chronic kidney disease stage III after living donor nephrectomy in a single institution annually. Methods: Between May 2006 and July 2017, a total of 753 living kidney donors who were followed up more than 6 months were enrolled in the study. We divided normal function vs chronic kidney disease III at 6 months postoperatively. We compared the incidence rate of chronic kidney disease stage III annually. For analysis, the entire period was divided into Era 1 (2006–2008), Era 2 (2009–2011), Era 3 (2012–2014), and Era 4 (2015–2017). Results: During the period, the incidence of chronic kidney disease stage III was 258 living donors (34.3{\%}). The prevalence of chronic kidney disease stage III was 39.3{\%}, 36.6{\%}, 35.5{\%}, and 29.3{\%} in Era 1, Era 2, Era 3, and Era 4, respectively. The rate of chronic kidney disease stage III incidence serially decreased as the era passed (P = .046). There was no difference in age, smoking status, drinking status, body mass index, preoperative cholesterol, and uric acid among the eras. However, preoperative estimated glomerular filtration rate was 90.86 (SD, 4.12), 94.47 (SD, 16.62), 103.82 (SD, 0.68), and 105.66 (SD, 19.57) mL/min/1.73 m2 in Era 1, Era 2, Era 3, and Era 4, respectively (P = .001). Conclusions: The incidence of chronic kidney disease stage III in living kidney donors for the last 3 years (Era 4) has decreased compared with the past (Era 1 and 2). The reason for this might be the effect of the change in the living donor guideline. Also, pre- and postoperative management method had an effect on renal function at 6 months.",
author = "Lee, {Hyung Ho} and Na, {Joon Chae} and Yoon, {Young Eun} and Lee, {Hyung Soon} and Huh, {Kyu Ha} and Kim, {Yu Seun} and Han, {Woong Kyu}",
year = "2019",
month = "10",
doi = "10.1016/j.transproceed.2019.03.058",
language = "English",
volume = "51",
pages = "2539--2542",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "8",

}

Yearly Trends of Chronic Kidney Disease III Progressions in Living Kidney Donors. / Lee, Hyung Ho; Na, Joon Chae; Yoon, Young Eun; Lee, Hyung Soon; Huh, Kyu Ha; Kim, Yu Seun; Han, Woong Kyu.

In: Transplantation Proceedings, Vol. 51, No. 8, 10.2019, p. 2539-2542.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Yearly Trends of Chronic Kidney Disease III Progressions in Living Kidney Donors

AU - Lee, Hyung Ho

AU - Na, Joon Chae

AU - Yoon, Young Eun

AU - Lee, Hyung Soon

AU - Huh, Kyu Ha

AU - Kim, Yu Seun

AU - Han, Woong Kyu

PY - 2019/10

Y1 - 2019/10

N2 - Purpose: We aim to see the rate of progression to chronic kidney disease stage III after living donor nephrectomy in a single institution annually. Methods: Between May 2006 and July 2017, a total of 753 living kidney donors who were followed up more than 6 months were enrolled in the study. We divided normal function vs chronic kidney disease III at 6 months postoperatively. We compared the incidence rate of chronic kidney disease stage III annually. For analysis, the entire period was divided into Era 1 (2006–2008), Era 2 (2009–2011), Era 3 (2012–2014), and Era 4 (2015–2017). Results: During the period, the incidence of chronic kidney disease stage III was 258 living donors (34.3%). The prevalence of chronic kidney disease stage III was 39.3%, 36.6%, 35.5%, and 29.3% in Era 1, Era 2, Era 3, and Era 4, respectively. The rate of chronic kidney disease stage III incidence serially decreased as the era passed (P = .046). There was no difference in age, smoking status, drinking status, body mass index, preoperative cholesterol, and uric acid among the eras. However, preoperative estimated glomerular filtration rate was 90.86 (SD, 4.12), 94.47 (SD, 16.62), 103.82 (SD, 0.68), and 105.66 (SD, 19.57) mL/min/1.73 m2 in Era 1, Era 2, Era 3, and Era 4, respectively (P = .001). Conclusions: The incidence of chronic kidney disease stage III in living kidney donors for the last 3 years (Era 4) has decreased compared with the past (Era 1 and 2). The reason for this might be the effect of the change in the living donor guideline. Also, pre- and postoperative management method had an effect on renal function at 6 months.

AB - Purpose: We aim to see the rate of progression to chronic kidney disease stage III after living donor nephrectomy in a single institution annually. Methods: Between May 2006 and July 2017, a total of 753 living kidney donors who were followed up more than 6 months were enrolled in the study. We divided normal function vs chronic kidney disease III at 6 months postoperatively. We compared the incidence rate of chronic kidney disease stage III annually. For analysis, the entire period was divided into Era 1 (2006–2008), Era 2 (2009–2011), Era 3 (2012–2014), and Era 4 (2015–2017). Results: During the period, the incidence of chronic kidney disease stage III was 258 living donors (34.3%). The prevalence of chronic kidney disease stage III was 39.3%, 36.6%, 35.5%, and 29.3% in Era 1, Era 2, Era 3, and Era 4, respectively. The rate of chronic kidney disease stage III incidence serially decreased as the era passed (P = .046). There was no difference in age, smoking status, drinking status, body mass index, preoperative cholesterol, and uric acid among the eras. However, preoperative estimated glomerular filtration rate was 90.86 (SD, 4.12), 94.47 (SD, 16.62), 103.82 (SD, 0.68), and 105.66 (SD, 19.57) mL/min/1.73 m2 in Era 1, Era 2, Era 3, and Era 4, respectively (P = .001). Conclusions: The incidence of chronic kidney disease stage III in living kidney donors for the last 3 years (Era 4) has decreased compared with the past (Era 1 and 2). The reason for this might be the effect of the change in the living donor guideline. Also, pre- and postoperative management method had an effect on renal function at 6 months.

UR - http://www.scopus.com/inward/record.url?scp=85070922562&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070922562&partnerID=8YFLogxK

U2 - 10.1016/j.transproceed.2019.03.058

DO - 10.1016/j.transproceed.2019.03.058

M3 - Article

C2 - 31447190

AN - SCOPUS:85070922562

VL - 51

SP - 2539

EP - 2542

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 8

ER -